Aspire Biopharma Holdings (ASBP) Treasury Shares (2022 - 2024)

Aspire Biopharma Holdings (ASBP) has reported Treasury Shares for 3 consecutive years, with $577644.0 the latest figure, recorded in Q4 2024.

• On a quarterly basis, Treasury Shares fell 67.98% year-over-year to $577644.0 in Q4 2024; TTM through Dec 2024 was $577644.0, a 67.98% decrease from a year earlier, with the FY2024 full-year figure at $577644.0, down 67.98% from the prior year.
• Treasury Shares was $577644.0 for Q4 2024 at Aspire Biopharma Holdings, roughly flat from $577644.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $28.8 million in Q4 2022 and troughed at $577644.0 in Q2 2024.
• A 3-year average of $7.4 million and a median of $1.8 million in 2023 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 93.73% in 2023 and slumped 67.98% in 2024, its largest moves.
• Over 3 years, Treasury Shares stood at $28.8 million in 2022, then sank by 93.73% to $1.8 million in 2023, then tumbled by 67.98% to $577644.0 in 2024.
• The last three Treasury Shares figures came in at $577644.0 (Q4 2024), $577644.0 (Q3 2024), and $577644.0 (Q2 2024), per Business Quant data.